| 注册
首页|期刊导航|西部中医药|黄芪桂枝五物汤治疗神经根型颈椎病的贝叶斯Meta分析

黄芪桂枝五物汤治疗神经根型颈椎病的贝叶斯Meta分析

瞿清辉 许金海 莫文

西部中医药2026,Vol.39Issue(6):49-54,6.
西部中医药2026,Vol.39Issue(6):49-54,6.DOI:10.12174/j.issn.2096-9600.2026.06.11

黄芪桂枝五物汤治疗神经根型颈椎病的贝叶斯Meta分析

Bayesian Meta-Analysis of Huangqi Guizhi Wuwu Decoction in the Treatment of Cervical Radiculopathy

瞿清辉 1许金海 1莫文1

作者信息

  • 1. 上海中医药大学附属龙华医院,上海 200032
  • 折叠

摘要

Abstract

Objective:To assess the efficacy and safety of Huangqi Guizhi Wuwu decoction in the treatment of cervical radiculopathy(CR)using Bayesian meta-analysis.Methods:Randomized controlled trials(RCTs)on Huangqi Guizhi Wuwu Decoction for the treatment of CR were retrieved from PubMed,Embase,Cochrane Library,and China National Knowledge Infrastructure(CNKI)databases from their inception to March 2023.Two independent researchers performed literature screening and data extraction.Bias risk assessment was conducted using RevMan 5.3 software,and Bayesian meta-analysis was performed using Stata 14.0 software.Results:A total of 15 randomized controlled trials were included.Bayesian random-effects meta-analysis showed that,compared with other therapies,Huangqi Guizhi Wuwu Decoction significantly improved the total effective rate(SMD=3.58,95%CI:3.18-7.02,P<0.000 01),VAS scores(SMD=-1.03,95%CI:-1.96--0.10,P=0.03),the scores of symptoms and body signs(SMD=-2.13,95%CI:-3.18--1.08,P<0.001),and cervical function score(SMD=4.92,95%CI:4.15-5.69,P<0.001),with low incidence of adverse reactions(SMD=-0.01,95%CI:-0.03--0.01,P=0.47).Conclusion:Huangqi Guizhi Wuwu decoction could improve the clinical efficacy for CR patients,effectively alleviate symptoms,enhance quality of life,and has a favorable safety profile.

关键词

颈椎病,神经根型/黄芪桂枝五物汤/贝叶斯Meta分析/疗效/安全性

Key words

cervical spondylosis,radiculopathy/Huangqi Guizhi Wuwu decoction/Bayesian meta-analysis/clinical effects/safety

分类

医药卫生

引用本文复制引用

瞿清辉,许金海,莫文..黄芪桂枝五物汤治疗神经根型颈椎病的贝叶斯Meta分析[J].西部中医药,2026,39(6):49-54,6.

基金项目

上海卫生健康委员会海派中医流派传承创新团队(2021LPTD-008) (2021LPTD-008)

中医非药物疗法示范中心建设(ZY[2021-2023]-0204-06). (ZY[2021-2023]-0204-06)

西部中医药

1004-6852

访问量0
|
下载量0
段落导航相关论文